TIDMVOY
RNS Number : 5945T
Voyager Life PLC
21 March 2023
21 March 2023
Voyager Life plc
("Voyager" or the "Company")
Result of General Meeting, Additional Subscription and Issue of
Equity
The General Meeting of the Shareholders of Voyager was held
yesterday at 11.00 am (UK) at Tay House, Riverview Business Park,
Friarton Road, Perth, Perthshire PH2 8DF. The Company is pleased to
confirm that all resolutions were duly passed and announces a
further subscription of new ordinary shares in the Company by an
existing shareholder for GBP20,000.
Full details of the poll results are set out below:
Percentage
Discretion of Voting
Resolution For Against to Chairman Rights Withheld Total
01 558,631 Nil Nil 4.60% 2,161,776 2,720,407
---------- -------- ------------- ----------- ---------- ----------
02 2,720,407 Nil Nil 22.38% Nil 2,720,407
---------- -------- ------------- ----------- ---------- ----------
03 2,720,407 Nil Nil 22.38% Nil 2,720,407
---------- -------- ------------- ----------- ---------- ----------
The number of ordinary shares in issue at 6:30 p.m. (UK) on 17
March 2023 was 12,152,912 . The Company does not hold any shares in
treasury.
Additional Subscription and Issue of Equity
Following approval of Rule 9 Waiver granted under the Takeover
Code, Eric Boyle, chairman, and Nick Tulloch, CEO, have each
subscribed for 833,333 new ordinary shares of 1 pence each ("New
Ordinary Shares") at a price of 12 pence per New Ordinary Share
with a warrant to subscribe for an additional New Ordinary Share at
an exercise price of 20 pence. These are the same terms as the
fundraise announced at the time of the Company's acquisition of the
CBD extraction and manufacturing facility in Poland from Goodbody
Health Limited on 16 December 2022.
In addition, an existing shareholder has also subscribed for
166,666 New Ordinary Shares at a price of 12 pence per New Ordinary
Share with a warrant to subscribe for an additional New Ordinary
Share at an exercise price of 20 pence raising further funds of
GBP20,000 for Voyager.
Admission
Application has been made for 1,833,332 new ordinary shares to
be admitted to trading on the Aquis Stock Exchange Growth Market
("Admission"). Admission is expected to occur at 8:00 am on or
around 24 March 2023. The new ordinary shares will rank pari passu
with the existing ordinary shares.
Total Voting Rights
Following Admission, the Company's enlarged share capital will
comprise 13,986,244 ordinary shares ordinary shares of 1 pence
each. Therefore, the total number of voting rights in the Company
will be 13,986,244 . This figure may be used by shareholders as the
denominator for calculations by which they will determine if they
are required to notify their interest in the Company, or a change
to their interest in the Company, under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.
This announcement contains inside information for the purposes
of the UK Market Abuse Regulation and the Directors of the Company
are responsible for the release of this announcement.
S
Enquiries:
Voyager Life plc Tel: +44 (0) 1738 317
693
Nick Tulloch, CEO
http://voyagerlife.uk
nick@voyagerlife.uk
Cairn Financial Advisers LLP (AQSE Tel: +44 (0) 20 7213
Corporate Adviser) 0880
Ludovico Lazzaretti/Liam Murray
Stanford Capital Partners LLP (Broker)
Patrick Claridge +44 (0) 203 3650 3650
Bob Pountney +44 (0) 203 3650 3651
John Howes +44 (0) 203 3650 3652
Notes to Editors:
About Voyager
Voyager was founded in 2020 and is based in Perth, Scotland. The
Company's primary objective is the formulation and supply of high
quality CBD and hemp seed oil products although it also produces
several other complementary products, the majority of which are
manufactured from the hemp plant. Its product categories include a
pet range which has rapidly developed into one of the Company's
best sellers. The Company sells online, through third party stores
and in its own stores which are located in St Andrews, Edinburgh
and Dundee. The Company has two principal retail brands: Voyager,
focused on health & wellness, and Ascend Skincare, its beauty
range. Voyager products are currently available from Cornwall to
Shetland in over 150 online and brick-and-mortar outlets. In
December 2022, with the aim of expanding its manufacturing
capability for EU markets, Voyager purchased a state-of-the-art CBD
extraction and manufacturing facility in Poland.
The Company's philosophy of plant-based health and wellness is
embodied in its mission statement and hashtag of "Choose you". With
an experienced team and a product line created in line with the
UK's regulatory regime, Voyager aims to become the trusted brand in
this increasingly popular health and wellness space.
Through Voyager's bespoke skincare product creation and
development division , voyagerCann , the Company also offers a full
turnkey service to other CBD, skincare and cosmetics brands
assisting them in developing and launching new products with
manufacturing and distribution facilities in Scotland and
Poland.
Website and social media links:
Voyager:
https://voyagercbd.com/
https://www.instagram.com/voyagercbd/
https://twitter.com/voyagercbd
https://www.linkedin.com/company/voyager-cbd/
https://www.facebook.com/voyagercbd/
voyagerCann:
https://voyagercann.com/
https://www.instagram.com/voyagercann/
https://twitter.com/voyagercann/
https://www.linkedin.com/company/voyagercann/
https://www.facebook.com/voyagercann/
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Nicholas Tulloch
--------------------------------------- -----------------------------------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------------------------------------------
a) Position / status CEO
--------------------------------------- -----------------------------------------------------------------------
b) Initial notification / amendment Initial notification
--------------------------------------- -----------------------------------------------------------------------
3. Details of the issuer, UK emission allowance market participant, auction platform or auctioneer
----------------------------------------------------------------------------------------------------------------
a) Name Voyager Life plc
--------------------------------------- -----------------------------------------------------------------------
b) LEI 213800XIUQ3AHRZ6UF89
--------------------------------------- -----------------------------------------------------------------------
2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----------------------------------------------------------------------------------------------------------------
a) Description of the financial Subscription of new o rdinary shares of 1 pence each and issue of
instrument warrants over new o rdinary
shares of 1 pence each
--------------------------------------- -----------------------------------------------------------------------
b) Nature of the transaction Investment in the Company following approval of the Rule 9 Waiver
granted by the Takeover
Panel
--------------------------------------- -----------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------------------------------------- ------------------------------
12 pence 833,333
------------------------------------------------------------------------------------ ------------------------------
20 pence (warrants) 833,333
------------------------------------------------------------------------------------ ------------------------------
d) Aggregated information Aggregated N/A
volume Price
--------------------------------------- -----------------------------------------------------------------------
e) Date of the transaction 20 March 2023
--------------------------------------- -----------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
--------------------------------------- -----------------------------------------------------------------------
1. Details of PDMR / person closely associated with them ("PCA")
----------------------------------------------------------------------------------------------------------------
a) Name Eric Boyle
--------------------------------------- -----------------------------------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------------------------------------------
a) Position / status Chairman
--------------------------------------- -----------------------------------------------------------------------
b) Initial notification / amendment Initial notification
--------------------------------------- -----------------------------------------------------------------------
3. Details of the issuer, UK emission allowance market participant, auction platform or auctioneer
----------------------------------------------------------------------------------------------------------------
a) Name Voyager Life plc
--------------------------------------- -----------------------------------------------------------------------
b) LEI 213800XIUQ3AHRZ6UF89
--------------------------------------- -----------------------------------------------------------------------
2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----------------------------------------------------------------------------------------------------------------
a) Description of the financial Subscription of new o rdinary shares of 1 pence each and issue of
instrument warrants over new o rdinary
shares of 1 pence each
--------------------------------------- -----------------------------------------------------------------------
b) Nature of the transaction Investment in the Company following approval of the Rule 9 Waiver
granted by the Takeover
Panel
--------------------------------------- -----------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------------------------------------- ------------------------------
12 pence 833,333
------------------------------------------------------------------------------------ ------------------------------
20 pence (warrants) 833,333
------------------------------------------------------------------------------------ ------------------------------
d) Aggregated information Aggregated N/A
volume Price
--------------------------------------- -----------------------------------------------------------------------
e) Date of the transaction 20 March 2023
--------------------------------------- -----------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
--------------------------------------- -----------------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXGZGZFMGKGFZZ
(END) Dow Jones Newswires
March 21, 2023 03:00 ET (07:00 GMT)
Grafico Azioni Voyager Life (AQSE:VOY)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Voyager Life (AQSE:VOY)
Storico
Da Set 2023 a Set 2024